Cancer Genome Analysis

• Conditions: Malignant Tumor
• Interventions: Other: next generation sequencing

• Registration Number: NCT01458704
• Lead Sponsor: Seoul National University Hospital

Brief Summary

Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-08
• Status Verified: 2011-10
• Study First Submitted: 2011-10-23
• Study First Submitted QC: 2011-10-24
• Last Update Submitted: 2011-10-24
• Study First Posted: 2011-10-25
• Last Update Posted: 2011-10-25
• Primary Completion: 2013-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• patients with malignant tumor
• receiving or planning to receive chemotherapy
• with fresh frozen tumor tissue
• with informed consent

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
fresh frozen tumor tissue	next generation sequencing	patients providing fresh frozen tumor tissue

Primary Outcome Measures

Name	Time	Method
targeted sequencing of cancer-relate genes	1 year	Identification and characterization of genetic alteration in cancer tissue

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of